ZORACTONE

This brand name is authorized in Nigeria.

Active ingredients

The drug ZORACTONE contains one active pharmaceutical ingredient (API):

1	Spironolactone UNII 27O7W4T232 - SPIRONOLACTONE
	Spironolactone, as a competitive aldosterone antagonist, increases sodium excretion whilst reducing potassium loss at the distal renal tubule. It has a gradual and prolonged action.
	Read more about Spironolactone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9859	Tablet	Zoractone 25 mg Tab TAB 25 mg 1 x 500's (in plastic jar)	Oral Tablet ZORACTONE 25MG TAB SPIRONOLACTONE BP 25MG EACH FILM COATED SPIRONOLACTONE BP 25MG EXCIPIENTS Calcium Sulfate Dihydrate BP Microcrystalline Cellulose BP Sodium Starch Glycolate BP Lactose Monohydrate BP Povidone (P.V.P.K-30) BP Iso propyl alcohol BP Colloidal anhydrous silica BP Magnesium Stearate BP B4-9859 Drugs Imported Products 1X500 POM 1 08/04/2024 ZMC INTERNATIONAL LIMITED., 7A NIGER STREET,KANO, KANO STATE, NIGERIA 576768789 zmcinternational18@gmail.com APEX FORMULATIONS PVT LTD, 1276, RAJPUR, ZULASAN ROAD, AHMEDABAD - MEHSANA HIGHWAY, DIST, MEHSANA GUJARAT, INDIA, India	28/08/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C03DA01	Spironolactone	C Cardiovascular system → C03 Diuretics → C03D Potassium-sparing agents → C03DA Aldosterone antagonists
Discover more medicines within C03DA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9859